MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about change in KMPs

16 Jul 2022 Evaluate

Jagsonpal Pharmaceuticals has informed that the Board of Directors at their meeting held today has approved changes in KMPs authorized for the purpose of determining materiality of an event or information and for the purpose of making disclosures to stock exchange(s) under the SEBI LODR. The contact details of the KMPs authorized is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..